Top Markets
Coin of the day
Bloomage BioTechnology Corporation Limited Bloomage BioTechnology Corporation Limited

Bloomage BioTechnology Corporation Limited

688363
Pozycja w akcjach #5711
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and... Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
Cena akcji
$5.21
Kapitalizacja rynkowa
$2.49B
Zmiana (1 dzień)
-0.91%
Zmiana (1 rok)
-34.46%
Kraj
CN
Handel Bloomage BioTechnology Corporation Limited (688363)
EPS dla Bloomage BioTechnology Corporation Limited (688363)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Bloomage BioTechnology Corporation Limited, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Bloomage BioTechnology Corporation Limited od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
$15.56 -
GB
- -
FR
$10.95 -
US
$7.50 -
US
$-0.21 -
US